Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

RG Carbone, S Negrini, F Puppo - Heart, Lung and Circulation, 2023 - heartlungcirc.org
The incidence of chronic kidney disease (CKD) is increasing worldwide, and the current
prevalence rate is about 8%-16%[1]. More than half a million adults in the USA have CKD …
相关文章

[引用][C] Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

RG Carbone, S Negrini… - Heart, lung & circulation, 2023 - pubmed.ncbi.nlm.nih.gov
Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in
Haemodialysis-Treated Patients: Time for a Treatment Shift? Letter to the Editor Regarding …

[引用][C] Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

RG Carbone, S Negrini, F Puppo - Heart, Lung & Circulation, 2023 - europepmc.org
Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in
Haemodialysis-Treated Patients: Time for a Treatment Shift? - Abstract - Europe PMC Sign in …